Delivery Order SPE2DB20D2104-SPE2DB25FMMHH
Award Date
3/31/25
Potential Completion Date
4/1/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,347.30, is for the delivery of Dupixent 300 mg/2 ml pen injectors. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,363.04, is for the supply of Dupixent 300 mg/2 ml pen injectors. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,513.53, is a Firm Fixed Price Delivery Order for the supply of Dupixent 300 mg/2 ml pen injections. The contract has an ultimate completion date of November 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen injectors. The contract has a firm fixed price of $90,106.16 and a period of performance through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,406.15 Firm Fixed Price Delivery Order contract covers the supply of Dupixent 300 mg/2 ml pen injectors, with a period of performance through September 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is for the delivery of Dupixent 300 mg/2 ml pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $2,538.70, has an ultimate completion date of April 8, 2024. This award was not set aside for any specific business type. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,538.96, is for the delivery of Dupixent 300 mg/2 ml pen injectors. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to supply the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract, valued at $37,165.78, has a firm fixed price and is scheduled for completion by September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen injectors. The $66,553.78 firm fixed-price delivery order is not set aside for any specific business category. It is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $40,229.42 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pen injectors. The award is not set-aside and has an ultimate completion date of August 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies, including...